Home > Boards > US OTC > Biotechs > Ampio Pharmaceuticals, Inc (AMPE)

Less "old-fashion P&D"...early am's opening was More Of

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
0210 Member Profile
Member Level 
Followed By 53
Posts 2,471
Boards Moderated 0
Alias Born 11/12/10
160x600 placeholder
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number PR Newswire (US) - 12/4/2019 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 4:34:23 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 10/31/2019 4:31:35 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/29/2019 6:03:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/21/2019 4:36:09 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 10/16/2019 4:03:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2019 4:02:31 PM
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility PR Newswire (US) - 10/10/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 4:02:57 PM
Ampio Retains Legal Counsel for Transaction Advisory Committee PR Newswire (US) - 9/18/2019 8:30:00 AM
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial PR Newswire (US) - 9/17/2019 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:47:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:32:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/11/2019 5:13:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 4:03:17 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/22/2019 3:05:35 PM
Ampio Pharmaceuticals Retains Financial Advisor and Appoints Transaction Advisory Committee PR Newswire (US) - 8/22/2019 8:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/9/2019 4:04:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/1/2019 5:23:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/1/2019 5:01:31 PM
Ampio Pharmaceuticals Updates Progress of SPA Clinical Trial PR Newswire (US) - 7/25/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/11/2019 4:02:23 PM
Ampio Appoints Moss Adams LLP as the Company's New Independent Auditor PR Newswire (US) - 7/11/2019 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/10/2019 4:03:12 PM
Ampio Appoints Dan Stokely as the Company's new Chief Financial Officer PR Newswire (US) - 7/10/2019 8:30:00 AM
0210 Member Level  Saturday, 06/15/19 03:32:29 PM
Re: ClayTrader post# 690
Post # of 740 
Less "old-fashion P&D"...early am's opening was More Of surge triggered by (squeezed)SHORTs Covering(MW estimates Shorts @26% of 86.6m float or 23m shares vs. 17m shares traded!!! Click here.), followed by usual profit-taking(+100% daily ROIs!!!), then spooked After Hours by OLD & Re-hashed News re: Capital Raise, which has been known since the Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) on August 8, 2018. At that time, AMPE dropped from $3+ pps.***

***AMPE Price Action, early August, 2018.

Aug 10, 2018 0.5000 0.6800 0.4900 0.5500 0.5500 11,041,400
Aug 09, 2018 0.3700 0.4800 0.3500 0.4800 0.4800 19,657,500
Aug 08, 2018 0.8700 0.9800 0.5900 0.6100 0.6100 18,728,700
Aug 07, 2018 2.9800 3.0100 2.8100 2.8600 2.8600 3,004,900
Aug 06, 2018 2.7500 2.9900 2.6600 2.9200 2.9200 1,616,800
Aug 03, 2018 3.0200 3.0800 2.5000 2.5700 2.5700 1,228,800
Aug 02, 2018 3.0200 3.0900 2.8500 2.9800 2.9800 930,400
Aug 01, 2018 2.9600 3.0700 2.9000 3.0200 3.0200 665,400

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist